Egalet Corporation

Egalet Corporation company information, Employees & Contact Information

Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products: ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII, developed using Egalet’s proprietary Guardian™ Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray. Using Guardian Technology Egalet is developing a pipeline of clinical-stage, product candidates including Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Guardian Technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredients with similar or different release profiles. For full prescribing information on ARYMO ER, including the boxed warning and medication guide, please visit arymoer.com. For full prescribing information on SPRIX, including the boxed warning and medication guide, please visit sprix.com. For full prescribing information on OXAYDO, including the boxed warning, please visit oxaydo.com. For additional information on Egalet, please visit egalet.com.

Company Details

Employees
14
Address
600 Lee Road,
Phone
45-44-47-80-80
Email
in****@****let.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
egalet.com
HQ
Wayne, PA
Looking for a particular Egalet Corporation employee's phone or email?

Egalet Corporation Questions

News

Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products - PR Newswire

Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products PR Newswire

National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management - NLL - National Lacrosse League

National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management - NLL National Lacrosse League

Egalet Receives FDA Approval for ARYMO™ ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain - MultiVu

Egalet Receives FDA Approval for ARYMO™ ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain MultiVu

This arthritis drug cost $198 in 2008. Now it's more than $10,000 - Axios

This arthritis drug cost $198 in 2008. Now it's more than $10,000 Axios

Egalet, Shionogi Enter Development/License Agreement - Contract Pharma

Egalet, Shionogi Enter Development/License Agreement Contract Pharma

An 'indestructible' long-acting painkiller just got approved by the FDA - businessinsider.com

An 'indestructible' long-acting painkiller just got approved by the FDA businessinsider.com

Why the FDA Approved Local Firm’s Abuse-Deterrent Opioid - Philadelphia Magazine

Why the FDA Approved Local Firm’s Abuse-Deterrent Opioid Philadelphia Magazine

Egalet stops making tamper-resistant opioid Arymo ER - The Business Journals

Egalet stops making tamper-resistant opioid Arymo ER The Business Journals

Egalet Announces Scientific Presentations At American Pain Society - BioSpace

Egalet Announces Scientific Presentations At American Pain Society BioSpace

Egalet Says Received Notice From Teva Pharmaceuticals USA Of ANDA Submission For Approval To Market Generic Version Of Arymo ER Extended-Release Tablets - Reuters

Egalet Says Received Notice From Teva Pharmaceuticals USA Of ANDA Submission For Approval To Market Generic Version Of Arymo ER Extended-Release Tablets Reuters

Delco pharma company expands outside U.S. - PhillyVoice

Delco pharma company expands outside U.S. PhillyVoice

Purdue Pharma Announces Patent Agreement with Egalet and Acura - PR Newswire

Purdue Pharma Announces Patent Agreement with Egalet and Acura PR Newswire

This indestructible pill is an answer to the massive overdose problem Obama mentioned last night - businessinsider.com

This indestructible pill is an answer to the massive overdose problem Obama mentioned last night businessinsider.com

Delco pharma company launches abuse-resistant painkiller - PhillyVoice

Delco pharma company launches abuse-resistant painkiller PhillyVoice

Top Egalet Corporation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant